Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Graves' disease is a complex autoimmune disorder in which several genetic susceptibility loci and environmental factors are likely to contribute to the development of disease. HLA and the CTLA-4 gene region have been established as susceptibility loci, although the magnitude of their contributions seems to vary between data sets and geographic populations. Genome-wide searches are beginning to identify new loci, including GD-1, GD-2, and GD-3, although these loci have only been found in one data set. Additional loci are likely to be identified via a combination of genome-wide linkage analysis and allelic association analysis of candidate genes.


Journal article


Endocrinol Metab Clin North Am

Publication Date





255 - 266


Abatacept, Antigens, CD, Antigens, Differentiation, CTLA-4 Antigen, Genetic Linkage, Genetic Predisposition to Disease, Graves Disease, HLA Antigens, Humans, Immunoconjugates, Major Histocompatibility Complex, T-Lymphocytes, Cytotoxic